{"symbol":"BSX","fiscalQuarter":"Q1-2017","reportDate":"2017-04-27","reportTime":"BMO","status":"reported","company":{"name":"Boston Scientific Corporation","sector":"Health Care","industry":"Health Care Equipment"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BSX/earnings/Q1-2017","postBrief":{"headline":"Boston Scientific Misses on EPS, Stock Up 0.81%","keyNumbers":[{"metric":"EPS","actual":"$0.29","expected":"N/A","surprise":"-4.55%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Cautiously Optimistic","keyQuotes":["Management highlighted ongoing investments in innovation.","They expressed confidence in long-term growth despite current challenges."],"summary":"Overall, management conveyed a sense of cautious optimism about future prospects. They emphasized their commitment to innovation and growth."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"Boston Scientific's earnings report showed a slight miss on EPS, which may raise some concerns among investors. However, the stock reacted positively, gaining 0.81%, likely due to management's focus on innovation and long-term growth strategies. The lack of revenue data and guidance leaves some uncertainty for future performance.","metaDescription":"Boston Scientific (BSX) Q1 2017 earnings: EPS missed expectations. Stock up 0.81%. Full breakdown."}}